Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Cancer Immunology Research
|
September 13, 2024
PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in Glioblastoma
Darel Martinez Bedoya, Eliana Marinari, Suzel Davanture, et al.
Brain : a Journal of Neurology
|
March 16, 2012
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
Valérie Dutoit, Christel Herold-Mende, Norbert Hilf, et al.
European Urology
|
April 16, 2013
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Arnoud J Templeton, Valérie Dutoit, Richard Cathomas, et al.
Immunological Reviews
|
November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma
Pedro Romero, Danila Valmori, Mikael J Pittet, et al.
European Journal of Immunology
|
October 30, 2008
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Donatella Ciuffreda, Denis Comte, Matthias Cavassini, et al.
Neuro-Oncology
|
February 13, 2019
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients
Denis Migliorini, Valérie Dutoit, Mathilde Allard, et al.
Communications Biology
|
June 11, 2021
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
Laetitia Seguin, Soline Odouard, Francesca Corlazzoli, et al.
Iscience
|
January 3, 2022
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer
Natacha Bordry, Alfredo Addeo, Cyril Jaksic, et al.
Cancer Cell
|
December 5, 2017
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma
Érika Cosset, Sten Ilmjärv, Valérie Dutoit, et al.
Cell Death & Disease
|
September 25, 2023
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma
Arthur Bassot, Helena Dragic, Sarah Al Haddad, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Cancer Immunology Research
|
September 13, 2024
PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in Glioblastoma
Darel Martinez Bedoya, Eliana Marinari, Suzel Davanture, et al.
Brain : a Journal of Neurology
|
March 16, 2012
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
Valérie Dutoit, Christel Herold-Mende, Norbert Hilf, et al.
European Urology
|
April 16, 2013
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Arnoud J Templeton, Valérie Dutoit, Richard Cathomas, et al.
Immunological Reviews
|
November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma
Pedro Romero, Danila Valmori, Mikael J Pittet, et al.
European Journal of Immunology
|
October 30, 2008
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Donatella Ciuffreda, Denis Comte, Matthias Cavassini, et al.
Neuro-Oncology
|
February 13, 2019
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients
Denis Migliorini, Valérie Dutoit, Mathilde Allard, et al.
Communications Biology
|
June 11, 2021
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
Laetitia Seguin, Soline Odouard, Francesca Corlazzoli, et al.
Iscience
|
January 3, 2022
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer
Natacha Bordry, Alfredo Addeo, Cyril Jaksic, et al.
Cancer Cell
|
December 5, 2017
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma
Érika Cosset, Sten Ilmjärv, Valérie Dutoit, et al.
Cell Death & Disease
|
September 25, 2023
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma
Arthur Bassot, Helena Dragic, Sarah Al Haddad, et al.
Page
of 7